- Home
- REE vs RANI Comparison
REE vs RANI Comparison
Compare REE & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- RANI
- Stock Information
- Founded
- REE 2011
- RANI 2012
- Country
- REE Israel
- RANI United States
- Employees
- REE N/A
- RANI N/A
- Industry
- REE Auto Manufacturing
- RANI Medicinal Chemicals and Botanical Products
- Sector
- REE Consumer Discretionary
- RANI Health Care
- Exchange
- REE Nasdaq
- RANI Nasdaq
- Market Cap
- REE 22.4M
- RANI 24.2M
- IPO Year
- REE N/A
- RANI 2021
- Fundamental
- Price
- REE $1.21
- RANI $1.83
- Analyst Decision
- REE Strong Buy
- RANI Strong Buy
- Analyst Count
- REE 2
- RANI 6
- Target Price
- REE $11.75
- RANI $8.67
- AVG Volume (30 Days)
- REE 1.1M
- RANI 44.1M
- Earning Date
- REE 12-19-2025
- RANI 11-13-2025
- Dividend Yield
- REE N/A
- RANI N/A
- EPS Growth
- REE N/A
- RANI N/A
- EPS
- REE N/A
- RANI N/A
- Revenue
- REE $183,000.00
- RANI $1,200,000.00
- Revenue This Year
- REE $327.73
- RANI N/A
- Revenue Next Year
- REE $36,888.82
- RANI N/A
- P/E Ratio
- REE N/A
- RANI N/A
- Revenue Growth
- REE N/A
- RANI N/A
- 52 Week Low
- REE $0.53
- RANI $0.39
- 52 Week High
- REE $11.72
- RANI $3.87
- Technical
- Relative Strength Index (RSI)
- REE 63.27
- RANI 62.74
- Support Level
- REE $1.14
- RANI $0.46
- Resistance Level
- REE $1.41
- RANI $3.87
- Average True Range (ATR)
- REE 0.18
- RANI 0.44
- MACD
- REE 0.02
- RANI 0.17
- Stochastic Oscillator
- REE 42.82
- RANI 39.99
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.